
--- Page 1 ---
Surgical Pathology Report. Name: Case #: DOb: Collected: Gendet: Received: MRN: Reported: Location: Copy To: Physiclan:d Pathclogic Interpretation: Ic D - 0 -3 SENTINEL NODE #1: Carcinoma mfi(traHry ductl Nos 85o0]/j A. - No carcinoma seen in one lymph node (0/1). Sife: brot, Nos c50.9 3/1a/n hw - Immunohistochemistry for keratin is pending. B. SENTINEL NODE #2: - No carcinoma seen in one lymph node (0/1) UUID:0D24479F-2F86-43AC-AA81-83AAD99542C4 - Immunohistochemistry for keratin is pending TCGA-EW-A1PF-01A-PR Redacted c. SENTINEL NODE #3: - No carcinoma seen in two lymph nodes (0/2). - Immunohistochemistry for keratin is pending. D. RIght;BreaSt, ONe StitCh SupERIOR, TWO StITChes LATeRAL: - INFILTRATING DUCTAL CARCINOMA, moderately differentiated, Nottingham grade 2 (2+3+2=7), 2.0 cm in greatest dimension.d - Margins are free of invasive carcinoma  Lymphovascular invasion is not identified.  Prior biopsy slte  See tumor summary.  DUCTAL CARCiNOMA IN SITU, high nuciear grade (DIN 3) with expansive comedo necrosis, solid type, present in 2/10 slides and representing less than 5% of submitted tissue. - Margins free of DCIS. E. NON-SENTINEL LYMPH NODE: - No carcinoma seen in two lymph nodes (0/2). F. SENTINEL NODE #4: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. G. SENTINEL NODE #5: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. H. SENTINEL NODE #6:  No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. I. SENTINEL NODE #7: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending J. SENTINEL NODE #8: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending TUMQR SUMMARY Specimen:d Total breast (including nippie and skin) Procedure: - Total mastectomy (including nipple and skin) Lymph Node Sampling:

--- Page 2 ---
SURGICAL PATHOL Report - Sentinel lymph node(s) - Axillary dissection (partial or complete dissection) Specimen Integrity: - Single intact specimen (margins can be evaluated) Specimen Laterality: - Right Tumor Site: Invasive Carcinoma - Upper outer quadrant - Central Tumor Size: Size of Largest Invasive Carcinoma - Greatest dimension of largest focus of invasion over 0.1 cm: 2.0 cm - Additional dimensions: 2.0 x1.0 cm Tumor Focality: - Single focus of invasive carcinoma Macroscopic and Microscopic Extent of tumor: - Skin: Invasive carcinoma does not invade into the dernis or epidermis - Skeletal muscle: Skeletal muscle is present and is free of carcinoma Ductal Carcinoma In Situ (DCIS): - DCIS IS PRESENT - Extensive intraductal component (ElC) negative Size (Extent) of DCIS: -Estimated size (extent) of DCiS (greatest dimension using gross and microscopic evaluation) is at least: 5 cm *Number of blocks with DCIS: 2 *Number of blocks examined: 10 - Architectural Pattens: Solid - Nuclear Grade: Grade IlI (high) - Necrosis: Present, central (expansive *comedo" necrosis) Lobular Carcinoma In Situ (LCIS)  Not identifed Histologic Type of Invasive Carcinoma: - Invasive ductal carcinoma (no special type or not otherwise specifed) Histologic Grade: Nottingham Histologlc Score Glandular (Acinar/Tubular Differentiation:  Score 2 Nuclear Pieomorphism: Score 3 Mitotic Count:  Score 2 Overall Grade: Grade 2: score 7 Margins: - Margins uninvolved by invasive carcinoma Distance from closest margin: 6 mm (deep) - Margins uninvolved by DCIS Distance from closest margin: 14 mm (deep) Treatment Effect: Response to Presurgical (Neoadjuvant) therapy: -In the Breast:  No known presurgical therapy - In the Lymph Nodes: No known presurgical therapy Lymph-Vascular Invasion: Not identifled. *Dermal Lymph-Vascular Invasion: Not identified Lymph Nodes: Number of sentinel lymph nodes examined: 9 Total number of lymph nodes examined (sentinel and nonsentinel): 11 Number of lymph nodes with macrometastases (>0.2 cm):0 Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells): 0 Number of iymph nodes with isolated tumor cells (s0.2 mm and s200 cells): 0 *Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one leve! Immunohistochemistry pending Pathologic Staging (pTNM): pT1c N0 Mx Primary Tumor: pT1c Regional Lymph Nodes: pN0 Distant Metastasis: Not applicable Anclllary Studies: Estrogen Receptor:  Performed on another specimen : : Results: Immunoreactive tumor cells present (1%) Progesterone Receptor: - Performed on another specimen ): Results: Immunoreactive tumor cells present (1%) Page 2 of 5

--- Page 3 ---
SURGICAL PATHOL Report Her2: - Performed on another specimen ); Results: Negative AJCC c{sssification (7" od) (pTNM): pT1c N0 Mx 1D5-ER.Pg636-PRA485-HER2.H11-EGFR.Ai dies are anatye specific reagents (ASRs) validased ty our laborolory. These ASRs are clinically usefui inticators thas do nos reguire FDA appn oval. These clones are i pathologist a positive or negative. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s) for the specimen(s); and (ii) Rendered the diagnosis(es). ***Eiectronically Signed Out By*** Procedures/Addenda Adderdum Date Ordered: Status: Signed Out Date Complete: Date Reported: Addendum Piagnosis A: !mmunohistochemistry for keratin is negative. B: Immuhohistochemistry for keratin is negative. C: Immunohistochemistry for keratin is negative. F: Pending Immunohistochemistry (keratin). G: Immunohistochemistry for keratin is negative. H: Immunohistochemistry for keratin is negative. I: Immurohistochemistry for keratin is negative. J: Immunohistochomistry for keratin is negative. Intraoperative Consuitation A. Seninel node #1, FS: No carcinoma seen B.  Sentinel node #2, FS: No carcinoma seen C.  Sentinel node #3, FS: No carcinoma seen F. Sentinel node # 4, FS: No carcinoma seen G.  Sentinel node # 5, FS:  No carcinoma seen H.  Sentinel node #6, FS: No carcinoma seen I.  Sentinel node #7, FS: No carcinoma seen J.  Sentnel node #8, FS: No carcinoma seon MD Page 3 of 5

--- Page 4 ---
SURGICAL PATHOL Report Clinica History: None provided Operatlon Performed Right totai mastectomy with sentinel node and possible axillary dissection Pro Opprativo Dlagnosis: Right breast carcinoma Specin(en(s) Received: A: Sentinel node #1, FS B: Sentinel node #2, FS C: Sentipel node #3, FS D: Right|breast, one stitch superior, two stitches lateral E: Non sentinel lymph node F: Sentinel node # 4, FS G: Sentinel node # 5, FS H: Sentipel node #6, FS I: Sentinel node #7, FS J: Sentirel node #8, FS Gross Dencription: A. Received fresh is a yellow-tan tissue, measuring 1.6 x 1.1 x 0.2 cm. Bisected and submitted in toto in one cassette for frozen section. B. Received fresh is a tan-yellow tissue, 1.8 x 0.9 x 0.3 cm. Bisected and submitted in toto in one cassette for frozen. section. C. Received fresh are fragments of tan tissue, 3.1 x 2.1 x 0.3 cm.  Sections are submitted as follows: 1 Possible lymph node, bisected, for trozen section 2 Remaining tissue in toto D. Received in formalin is a total mastectomy weighing 450 grams, measuring 20.0 x 16.0 x 2.6 cm with a portion of skin 16.5 x 7.0 cm. The areola is 2.0 cm. in the upper outer portion of the breast 0.6 cm from the deep margin and 1.6 cm posterior to the skin at approximately 11 o'clock is an ill-defined fibrotic area 2.0 x 2.0 x 1.0 cm in dimenslon. No other lesions are grossly identified. Resection margins inked in black. Stroma to fat ratio is 5 to 95%. Sections submitted as follows: 1 Nipple (base of nippie) and tip in perpendicular sections 2&3 Composite section of the ill-defined mass in relation to the deep margin and to the anterior skin (Cassette 2 contains skin, cassette 3 contains deep margin) 4&5 Additional sections of lesion in relation to deep margin 6&7 Additional soctions of lesion in relation to surrounding breast tissue 8 Section from lower outer quadrant 9 Section from upper inner quadrant 10 Lower inner quadrant E. Received in formalin are multiple fragments of adipose tissue, 1.6 x 1.3 x 0.4 cm. The specimen is submitted in toto in one cassette. F. Received fresh is a tan-red tissue fragment, 0.9 x 0.6 x 0.2 cm.The specimen is bisected and submitted in toto in one. cassette for frozen section. G. Received fresh is a tan tissue fragment, 1.1 x 0.6 x 0.4 cm. The specimen is bisected and submitted in toto in one cassette for frozen section. H. Received fresh is tan tissue fragment, 1.1 x 0.6 x 0.3 cm.The specimen is bisected and submitted in toto in one cassette For frozen section.. Received fresh is a tan tissue fragment, 0.6 x 0.5 x 0.3 cm. The specimen is bisected and submitted in toto in one 1. cassette for frozen section. Page 4 of 5

--- Page 5 ---
SURGICAL PATHOL Report J. Received fresh is a tan tissue fragment, 0.7 x 0.4 x 0.3 cm. The specimen is submitted in toto in one cassette for frozen section. Page 5 of 5